Journal
/
/
分析EGFR突变型NSCLC患者衍生类器官靶向治疗的敏感性
JoVE 신문
암 연구학
This content is Free Access.
JoVE 신문 암 연구학
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
DOI:

08:52 min

November 22, 2021

, , ,

Chapters

  • 00:04Introduction
  • 01:05Generating Single-Cell Suspension
  • 02:38Cell Seeding
  • 04:39Drug Treatment
  • 05:37Readout by Luminescence-Based Survival Assay
  • 06:52Results: The Analysis of Treatment Response of EGFR-Mutant NSCLC Organoid Model to Osimertinib
  • 08:18Conclusion

Summary

자동 번역

该协议描述了NSCLC患者衍生类器官模型中靶向信号传导抑制剂药物敏感性的标准化评估。

Related Videos

Read Article